Implication of a New Molecule IK in CD34
" Hematopoietic Progenitor Cell Proliferation and Differentiation By Liang-Xian Cao, Marie-Caroline Le Bousse-Kerdilè s, Denis Clay, Sergey Oshevski, Claude Jasmin, and Patricia Krief HLA-DR is one of the markers associated with hematopoietic ages at each of the 3 and 5 ends and corresponding to the initiation site of IK mRNA. A control oligonucleotide was cell differentiation, since expression of this molecule is modulated throughout hematopoiesis. We have previously dealso tested in parallel. A specific decrease of IK transcripts was correlated with an increase of HLA-DR antigen expresscribed and cloned the gene encoding factor IK, which inhibits both interferon gamma (IFN-g)-induced and constitutive sion level. In colony-forming assays, IK antisense oligonucleotide inhibited colony formation by multilineage early ery-HLA-DR expression. The current study demonstrates that IK gene transcripts are present in CD34
" cells purified from throid and granulomonocytic CD34 " progenitors. The mean colony size was decreased 70% by IK antisense oligonucleohuman umbilical cord blood. IK expression increased and was therefore inversely correlated with the gradual loss of tide in comparison to controls. These results provide evidence that the IK molecule participates in the regulation of HLA-DR during growth factor-induced CD34
" cell proliferation and differentiation. To study the possible role of IK in HLA-DR expression on hematopoietic cells and plays a role in growth factor-dependent CD34 " cell proliferation and difhematopoiesis, antisense probes were used. IK expression was specifically inhibited by an antisense oligodeoxynucleoferentiation by modulating HLA-DR expression. ᭧ 1997 by The American Society of Hematology. tide containing two phosphorothioate internucleotide linkgrowth factor-dependent colony formation, indicating that
H

IK expression was required for in vitro CD34
/ progenitor EMATOPOIESIS IS A multistep cell proliferation and differentiation process that underlies the production proliferation and differentiation. of highly specialized cells from stem and progenitor cells. This complex process is regulated by a cascade of both positive and negative signals mediated by cell-cell contacts
MATERIALS AND METHODS
and cytokine-receptor interactions.
1,2 Due to recent progress
Cell line. The RJ2.2.5 cell line, a gift from R. Accolla (ABC, in growth factor biology and the development of hematopoi- Polymerase chain reaction. Semiquantitative polymerase chain serum (Flow Laboratories, Irvine, CA), 1% BSA (Sigma, St Louis, MO), 100 mmol/L 2-mercaptoethanol (Sigma), 1% L-glutamine reaction (PCR) was performed in a final volume of 25 mL; 2 mL cDNA reaction mixture was added to 11 PCR buffer (Boehringer, (GIBCO BRL), 1% antibiotic (Genzyme, Boston, MA), 2 U/mL EPO (Dompe Biotechnology, Milan, Italy), 100 U/mL IL-3 (Sandoz), 100 Mannheim, Germany), 200 mmol/L each of the four dNTPs (Promega), 1 mmol/L of each primer, 1.25 U Tag DNA (Boehringer), U/mL IL-1b (Genzyme), 100 U/mL IL-6 (Genzyme), 100 U/mL granulocyte/macrophage colony-stimulating factor (GM-CSF; Sanand 0.1 mCi [a 32 P]dCTP (NEN Research Products, Boston, MA). Conditions for the PCR were as follows: 94ЊC for 1 minute, 68ЊC doz), 100 U/mL G-CSF (Dompe Biotechnology), and 2 U/mL stem cell factor (SCF; Genzyme). We have previously established that for 2 minutes, and 72ЊC for 3 minutes. For glyceraldehyde phosphodehydrogenase (GAPDH), which was used as a control, the PCR this cytokine combination is optimal for maximal colony formation from either purified cord blood or bone marrow CD34 / cells. was set at 94ЊC for 1 minute, 58ЊC for 1.5 minutes, and 72ЊC for 2 minutes. Control reactions were performed to ensure that the condiDuplicate cultures were incubated at 37ЊC in a humidified atmosphere containing 5% CO 2 . The colony-forming units (CFU; ú50 tions used were within the linear range of PCR amplification for all samples tested. PCR products were separated on 5% polyacrylamide cells) were scored using an inverted microscope after 10 to 18 days of culture. Immature burst-forming units-erythroid (iBFU-E) gels and autoradiographed before quantification on a Molecular Dynamics Phosphorimager. For each experiment, the PCR was repeated and mature BFU-E (mBFU-E) were scored using criteria already described. 18 CFU-granulocyte/macrophage (CFU-GM) colonies in at least two different samples, and typical results are presented.
The primers were synthesized on an Oligo 1000 DNA synthesizer with high cell density and greater than 0.5 mm in diameter were scored as large CFU-GM, and CFU-GM colonies with lower cell (Beckman). The following primers were used for IK amplification: upper, 5CGGGGGAAGCTGGAAGAGAAGAAACCTCCTGAC-density and smaller than 0.5 mm in diameter were scored as small CFU-GM. GCTGACA (position 1 to 40), and lower, 5TTCCACTGGCGA-TCAAGCTCTGCTTTGTCATTGGTTTCCT (position 612 to 652).
Cell treatment with antisense oligonucleotides. A dose-dependent assay was performed on CD34 / cells to verify that the oligonuThe product derived from these primers contains the sequence corresponding to the target site of IK antisense oligonucleotide. fied from different cord blood samples (Fig 2A) / cells were cells, it is reasonable that progenitors express less IK than isolated from either umbilical cord blood or bone marrow differentiated hematopoietic cells. To verify this hypothesis, by density centrifugation followed by anti-CD34 antibody we picked cells from CFU-GM, CFU-G, CFU-M, and BFUpanning. Using this method, we can reproducibly obtain E colonies obtained from the proliferation and differentiation CD34 / cells expressing a high level of CD34 antigen (79.4 of CD34 / and analyzed IK expression. As expected, these AU) with a purity ranging from 97% to 99% (Fig 1B) . The cells expressed a higher level of IK transcripts than nondifmajority of these purified CD34
/ cells also expressed HLA-DR antigen (54.8 AU; Fig 1D) restricted to a specific lineage since cells from either myeloid This augmentation was correlated with a higher proportion of differentiated cells, since the percentage of promyeloor erythroid colonies expressed similar IK transcript levels (data not shown). We further examined IK expression in blasts and monoblasts increased from 3% to 4% on day 0 to 25% on day 6. Furthermore, we show that HLA-DR antigen different subsets of CD34 / cells. CD34 / DR low cells purified from bone marrow cells expressed a higher level of IK tranexpression gradually decreased during proliferation and differentiation of CD34 / progenitors (Fig 4) . scripts than CD34 / DR high cells (Fig 2B) . Altogether, our results show that IK expression was inversely correlated with
IK expression is decreased by IK antisense oligonucleotide treatment. Our results demonstrating that IK was ex-HLA-DR antigen expression in both CD34
/ progenitors and differentiated hematopoietic cells.
pressed in CD34 / cells and that its expression was increased during differentiation suggested that IK might play a role in IK expression is associated with growth factor-induced proliferation and differentiation of CD34 / cells. We anahematopoiesis. This hypothesis was evaluated by an oligonucleotide antisense method that has been previously used to lyzed the time course of IK expression by CD34
/ cells undergoing proliferation and differentiation in liquid cultures address the function of autocrine or paracrine cytokines or other hematopoietic regulators in immunomodulation and containing a combination of seven growth factors (IL-1, IL-3, IL-6, SCF, G-CSF, GM-CSF, and EPO). IK expression hematopoiesis regulation. 19, 20 In the present study, we used partially phosphorothioated antisense oligonucleotides ingradually increased with time and reached the highest level on day 6 of culture (Fig 3) . Compared with freshly isolated stead of the fully modified ones because the former have a lower resistance to nucleases than the latter and the partially CD34 / cells (day 0), IK expression was increased more than 15-fold on day 6 of culture (IK/GAPDH, 151.6% v 9.6%).
modified oligonucleotides present less sequence-independent cytotoxicity than the fully modified ones.
16,17 After 6 days in liquid culture containing growth factors, even at a final concentration of oligonucleotides as high as 20 mmol/L, cell viability assessed by the trypan blue exclusion test was higher than 95%. These data confirm that the oligonucleotides were not toxic to CD34 / cells. Several mechanisms are believed to be involved in the effects of antisense oligonucleotides in cells. 21, 22 One of these mechanisms is that the formation of oligonucleotide and target mRNA duplexes results in a degradation of the target mRNA by RNase H present in the cytoplasm. To determine whether IK antisense oligonucleotides used in this study could decrease IK expression, purified CD34 / cells were exposed to antisense or control oligonucleotides in liquid cultures containing IL-1, IL-3, and SCF. IK expression in purified CD34
/ cells was inhibited after a 24-hour treatment with IK antisense oligonucleotides, but not with control oligonucleotides (Fig 5) . Data are presented for AS1 and NS1.
IK antisense oligonucleotides prevented the decrease of For
IK antisense oligonucleotides impaired growth factordependent CD34
/ colony formation in semisolid medium and CD34
/ differentiation in short-term liquid culture. To determine the possible role of endogenous IK in regulating normal hematopoiesis, we plated cord blood CD34 / cells in semisolid medium containing a combination of seven growth factors plus either IK antisense or control oligonucleotides or control medium. In our experimental conditions, the cloning efficiency of untreated control CD34 / cells purified from cord blood was 40.2% { 2.9%. Indeed, from 500 plated CD34
/ cells, we could obtain 10.3 { 2.1 CFU-GEMM, 50.1 { 9.1 iBFU-E, 21.2 { 3.1 mBFU-E, 39.8 { 5.9 large CFU-GM, and 70.0 { 7.4 small CFU-GM. The total colony number was decreased by antisense oligonucleotide (AS1) in comparison to control treatment (MS1) (41.5% { 8.5% v 7.8% { 4.3%, P Å .0420, n Å 5; Fig 7A) . This reduction is mainly due to the inhibition of colony formation from primitive progenitors, since the number of CFU-GEMM, iBFU-E, and large CFU-GM was decreased by IK antisense v 13.5% { 9.0%, P Å .0079, n Å 5). We obtained similar results with AS2 and MS2 oligonucleotides. These results showed that addition of IK antisense oligonucleotides (AS1 or AS2) but not of control oligonucleotides (MS1 or MS2) tions, the majority of cells express low levels of CD34 antito purified CD34 / cell cultures resulted in an inhibition of gen (Fig 6B and C) and HLA-DR antigen (Fig 6F and G) colony formation, especially multilineage, early erythroid, whether they are untreated (control medium) or treated with and granulomonocytic colonies. No significant change in the control oligonucleotides. However, in the presence of IK percentage of small granulocytic or erythroid colonies was antisense oligonucleotides, most of the cells express high levels of CD34 and HLA-DR antigens (Fig 6D and H) .
observed after IK antisense oligonucleotide treatment in comparison to the control. Interestingly, we found that antiwell understood. CD34 / lymphohematopoietic progenitors express the three MHC class II molecules (HLA-DR, HLAsense oligonucleotide treatment mainly inhibited the granulocytic component of CFU-GM, but had no obvious effect DQ, and HLA-DP) with different intensities, with HLA-DR showing the highest expression on these progenitor cells. 15 on the macrophage component (data not shown). Whatever the cytologic type of the colony (CFU-GEMM, CFU-GM, It has been suggested that expression of HLA-DR is associated with the regulation of hematopoietic progenitor cell or BFU-E), the mean size was also remarkably decreased by antisense oligonucleotide treatment from 16.1 { 5.7 1 proliferation and differentiation. 13, 14 By using neutralizing MoAbs anti-HLA-DR, Mascle et al 23 ) were cultured in liquid medium supplemented with 20% FCS plus the seven factors, the addition of anti-MHC class II MoAbs resulted in a dosedependent decrease of CFU-GM precursors in long-term the total number of cells recovered after 6 days of culture was fivefold lower in the presence of antisense oligonucleobone marrow culture but had no effect on CFU-GM culture in agar, suggesting that additional factors including stromal tides (1.8 { 0.3 1 10 4 ) as compared with untreated CD34 / cells (9.4 { 1.2 1 10 4 ) or CD34 / cells treated with control cells and cytokines might also be involved in the anti-MHC class II-mediated hematopoiesis inhibition. Although these oligonucleotides (8.1 { 0.9 1 10 4 ). Furthermore, the percentage of differentiated cells (mainly promyelocytes) is also two studies might seem contradictory, they showed a correlation between the presence of HLA-DR and the ability for significantly decreased in the presence of antisense oligonucleotides (9% { 1%) in comparison to untreated or mockcolony formation by hematopoietic progenitors. However, until now, there has not been any direct evidence linking treated CD34
/ cells, in which the percentage of promyelocytes reached 25% { 6% on day 6 of culture. However, HLA-DR expression and hematopoietic differentiation. Previous results from our group have shown that IK when CD34
/ cells were plated in semisolid medium after oligonucleotide pretreatment for 2 weeks in liquid medium mRNA could be detected in a hematopoietic cell line 5 ; we presently report that IK is expressed in mononuclear cells containing seven growth factors, the number of high proliferative potential colony-forming cells (HPP-CFC) obtained and in CD34 / progenitors purified from either cord blood or bone marrow (Fig 2A) . Furthermore, our data indicate that was higher in culture pretreated with IK antisense oligonucleotide (21.5 { 4.9) compared with control oligonucleotide IK transcription also occurs in a subpopulation of primitive CD34 / cells expressing a low level of HLA-DR antigen (10.5 { 2.1) or control cultures (8.5 { 0.5).
(CD34 high DR low , Fig 2B) . IK expression is inversely corre- 
